Breaking News

You are here » Indian-Commodity  :  Commodities  :  Turmeric  :  Turmeric futures edge higher on NCDEX

11-Apr2018

Turmeric futures edge higher on NCDEX

Turmeric futures edged higher on NCDEX due to rising domestic demand in the spot market. Although, some gains were capped due to arrival of new season crop and lower export demand.

The contract for April delivery was trading at Rs 6432 .00, up by 0.03 % or Rs 2.00 from its previous closing of Rs 6430.00. The open interest of the contract stood at 2215 lots.

The contract for May delivery was trading at Rs 6528 .00, rose by 0.09 % or Rs 6.00 from its previous closing of Rs 6522.00. The open interest of the contract stood at 12745 lots on NCDEX.






Related News

View all news

Turmeric futures trade lower on higher production prospects

Turmeric futures traded lower on NCDEX, due to expectation of higher production prospects this season amid higher acreage in Telangana. However, good exports and improving domestic demand restricted some......

Turmeric futures trade higher on firm demand

Turmeric futures traded higher on NCDEX, in line with speculative positions built up by participants amid firm demand in domestic as well as export markets. However, reports on improved sowing in turmeric......

Turmeric futures trade lower on profit booking

Turmeric futures traded lower on NCDEX, as investors booked their profit at prevailing higher rates amid reports of higher turmeric acreage. However, strong domestic demand trimmed the some losses.The......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......